A detailed history of Pnc Financial Services Group, Inc. transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 353 shares of AURA stock, worth $1,952. This represents 0.0% of its overall portfolio holdings.

Number of Shares
353
Previous 141 150.35%
Holding current value
$1,952
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$5.88 - $7.23 $1,246 - $1,532
212 Added 150.35%
353 $2,000
Q2 2025

Aug 08, 2025

BUY
$4.9 - $6.97 $690 - $982
141 New
141 $0

Others Institutions Holding AURA

About Aura Biosciences, Inc.


  • Ticker AURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,273,600
  • Market Cap $162M
  • Description
  • Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...
More about AURA
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.